{
    "id": "12864366",
    "text": "{| id=\"drugInfoBox\" style=\"float: right; clear: right; margin: 0 0 0.5em 1em; background: #ffffff;\" class=\"toccolours\" border=0 cellpadding=0 align=right width=\"240px\" |- | align=\"center\" colspan=\"3\" | Illustration of an HLA-DR (Human MHC class II) antigen receptor with bound antigen |- | align=\"center\" colspan=\"2\" | major histocompatibility complex, class II, DR53 |- | bgcolor=\"#e7dcc3\" | Haplotypes | bgcolor=\"#eeeeee\" | DRA*01:DRB4*0101 DRA*01:DRB4*0102 DRA*01:DRB4*0103 DRA*01:DRB4*0104 |- | colspan=\"2\" bgcolor=\"#dddddd\" | Structure (See HLA-DR) |-style=\"background:#f8f8f8\" | bgcolor=\"#dddddd\" | Identifiers|| align=\"center\" | alpha *0101 |- | bgcolor=\"#e7dcc3\" | Symbol(s) | bgcolor=\"#eeeeee\" | HLA-DRA |- | bgcolor=\"#e7dcc3\" | EBI-HLA | bgcolor=\"#eeeeee\" | DRA*0101 |-style=\"background:#f8f8f8\" | bgcolor=\"#dddddd\" | Identifiers|| align=\"center\" | beta 4 *0101 *0102 *0103 *0104 |- | bgcolor=\"#e7dcc3\" | Symbol(s) | bgcolor=\"#eeeeee\" | HLA-DRB4 |- | bgcolor=\"#e7dcc3\" | EBI-HLA | bgcolor=\"#eeeeee\" | DRB4*0101 |- | bgcolor=\"#e7dcc3\" | EBI-HLA | bgcolor=\"#eeeeee\" | DRB4*0102 |- | bgcolor=\"#e7dcc3\" | EBI-HLA | bgcolor=\"#eeeeee\" | DRB4*0103 |- | bgcolor=\"#e7dcc3\" | EBI-HLA | bgcolor=\"#eeeeee\" | DRB4*0104 |- | colspan=\"2\" bgcolor=\"#dddddd\" | Shared data |- | bgcolor=\"#e7dcc3\" | Locus | bgcolor=\"#eeeeee\" | chr.6 6p21.31 |- |} HLA-DR53 is an HLA-DR serotype that recognizes gene products of HLA-DRB4 locus. There are 13 alleles at this locus that encode 7 proteins. DRB3, DRB4, and DRB5 are minor DR beta encoding loci, they have been recognized as having distinct evolution. and the DRB4 locus presence is linked to HLA-DR7 seropositivity. The DRB4*locus was apparently duplicated from an ancestor of the DRB1-DRB4 common locus around 5 million years ago. DRB4 locus is only apparent in a small subset of DQ haplotypes, and most individuals lack DRB4. In addition the level of normal expression is 8 fold lower than the DRB1 in cells which can express both. and lowered because of both transcriptional and post-transcriptional regulation. ==Alleles== {| border=\"0\" cellspacing=\"0\" cellpadding=\"0\" align=\"left\" style=\"text- align:center; background:#ffffff; margin-right: 3em; border:2px #e0e0ff solid;\" |+ DR53 recognition of some DRB4* allelesderived from IMGT/HLA |- style=\"background:#f0f0ff\" | style=\"width:60px\" | DRB4* || style=\"width:60px\" | DR53 | style=\"width:60px\" | ? || style=\"width:60px\" | Sample |- style=\"background:#f0f0ff\" | allele || % || % || size (N) |- | style = \"background:#e8e8f8\" | 0101 || 95 || || 38 |- | style = \"background:#e8e8f8\" | 0103 || 89 || || 49 |- |} DR53 reactive alleles: DRB4*0101, *0103 Unknown reactivity: *0102, *0104 to *0107 Null alleles: *0101102N, *01030102N, *0201N, *0301N ==Associated diseases== DRB4*01 is positively associated with Erythema multiforme, Crohn's disease, myasthenia gravis, rheumatoid arthritis Hashimoto's thyroiditis, vitiligo, primary biliary cirrhosis, clozapine- induced agranulocytosis, Vogt-Koyanagi-Harada disease, ==HLA-DRB1 linkage== HLA-DR53 serotypes (HLA-DRB4) is linked to the following HLADR serotypes (HLA- DRB1) allele groups: HLA-DR4 - DRB1*04 HLA-DR7 - DRB1*07 HLA-DR9 - DRB1*09 ==References== Category:HLA-DR haplotypes ",
    "title": "HLA-DR53"
}